FDA Issues EUA for Third Diagnostic SARS-CoV-2 POC Antigen Test
Update on emergency use authorization for third SARS-CoV-2 POC antigen test.
Clinical Laboratories May be Overlooking Coagulopathy Tests That Should Be Ordered for COVID-19 Positive Patients
In an exclusive interview, Joshua Hayden, PhD, DABCC, FAACC, of Norton Healthcare, discusses COVID-19 associated coagulopathy, PE, and a potential clinical laboratory testing strategy for COVID-19 positive follow-ups.
China-Based Autobio Diagnostics Becomes the Second Company to Have SARS-CoV-2 Serology Test EUA Revoked
What the National Cancer Institute (NCI) found toward the revocation of Autobio Diagnostics’ antibody test EUA.